Wedbush raised the firm’s price target on Super Micro (SMCI) to $40 from $24 and keeps a Neutral rating on the shares.Maximize Your Portfolio ...
Wedbush raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $81 from $77 and keeps an Outperform rating on the shares ...